Search
+
    SEARCHED FOR:

    REVERSE STOCK

    TCS reverses headcount trend, adds 5,452 employees in Q1 FY25

    TCS's Q1 FY25 net employee count grew by 5,452 to 606,998, as per stock exchanges. Post a 13,249 reduction in FY24 (first annual drop in 19 years) and a Q4FY24 staff cut. Consolidated net profit declined 3.16% QoQ to Rs 12,040 crore but increased YoY from Rs 11,074 crore. March and previous quarter noted 12.1% attrition.

    Stock Radar: Multibagger in a year! This lubricant stock forms Rounding Bottom formation; what should investors do?

    Tide Water Oil (India) Ltd. stock surged 123% over a year, breaking out from a Rounding Bottom pattern on weekly charts. Analyst set a target price of Rs 2,800 with a stop loss at Rs 1,800. The stock is above 21, 50, 100 WEMA, tracked by RSI above 70, and daily MACD.

    Budget 2024: India's FDI flows are dropping, can FM Sitharaman formulate policy measures to reverse the trend?

    Budget 2024 expectations: Union Budget 2024 is fast approaching, and Finance Minister Nirmala Sitharaman is expected to introduce more liberalized norms for foreign investments, as Foreign Direct Investments (FDIs) play a crucial role in the Indian economy's growth prospects. Net FDI inflow in the fourth quarter stood at $2.0 billion, down from $3.9 billion in the third quarter and $6.4 billion in the same period last year.

    Biotech firm Vyome Therapeutics to go public via reverse merger with Nasdaq-listed Reshape Lifesciences

    Vyome Therapeutics, a biotech company backed by Manipal group chief Ranjan Pai, will go public in the US through a reverse merger with US-based Reshape Lifesciences. Pai, along with investors Remus Capital and Iron Pillar will invest at least $7.3 million in the merged entity through a private placement.

    Weekly Top mid and smallcap picks: These mid and smallcap stocks scored 10 on 10 on Stock Reports Plus

    Stock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company analysis, the report also collates analysts’ forecasts and trend analysis for each component. An average score in Stock Reports Plus is calculated by undertaking quantitative analysis of five key investment tools - earnings, fundamentals, relative valuation, risk and price momentum.

    Stock Radar: This sugar stock is showing signs of bottoming out after 24% fall from highs; time to buy?

    Dalmia Bharat's stock stabilizes as experts recommend a bullish outlook, targeting above Rs 2,100 in the volatile sugar industry. The company's price movements reflect a harmonic pattern signaling potential reversals.

    The Economic Times
    BACK TO TOP